Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes

por Hae Kyung Kim, Minyoung Lee, Yong-ho Lee, Yong-ho Lee, Byung-Wan Lee, Byung-Wan Lee, Bong-Soo Cha, Bong-Soo Cha, Eun Seok Kang, Eun Seok Kang
Publicado 2021

Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway

por Ji-Yeon Lee, Minyoung Lee, Ji Young Lee, Jaehyun Bae, Eugene Shin, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
Publicado 2021

Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores.

por Yong-ho Lee, Heejung Bang, Young Min Park, Ji Cheol Bae, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Beverley Balkau, Won-Young Lee, Dae Jung Kim
Publicado 2014

SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease

por So Ra Kim, Sang-Guk Lee, Soo Hyun Kim, Jin Hee Kim, Eunhye Choi, Wonhee Cho, John Hoon Rim, Inhwa Hwang, Chan Joo Lee, Minyoung Lee, Chang-Myung Oh, Justin Y. Jeon, Heon Yung Gee, Jeong-Ho Kim, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Myung-Shik Lee, Je-Wook Yu, Jin Won Cho, Jung-Sun Kim, Yong-ho Lee
Publicado 2020